BIOEMTECH participated in the World Molecular Imaging Congress (WMIC) 2026 in Salt Lake City, together with our North American partners at LabLogic Systems.
During the congress, our team had the opportunity to connect with researchers and industry professionals working across molecular imaging, radiopharmaceutical development and targeted radionuclide therapy, and to discuss BIOEMTECH’s preclinical imaging systems and research services.
A key highlight of our participation was the presentation of new ²²⁵Ac imaging results generated using the 3D SPECT capability of γ-eye™. The poster, entitled “Longitudinal multi-window 3D SPECT imaging of [²²⁵Ac]Ac-DOTAGA-trastuzumab in a HER2-positive SKOV-3 xenograft model”, presented longitudinal tomographic imaging across multiple energy windows, demonstrating the potential of 3D SPECT for the preclinical evaluation of alpha-emitting radiopharmaceuticals.
We would like to thank everyone who visited our booth, attended the poster presentation or took the time to meet with our team during WMIC 2026.